Alessia Scatena
7PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 17, 2024
The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)-Rationale and Meta-Analysis of Observational Studies.Laura Rehak, Laura Giurato, Matteo Monami
|Nov 15, 2024
Autologous cell therapy for ischemic diabetic foot: a meta-analysis of randomized controlled trials for the development of the Italian guidelines for the treatment of diabetic foot syndrome.Alessia Scatena, Matteo Apicella, Michele Mantuano
|Oct 04, 2023
Bypass surgery versus endovascular revascularization for occlusive infrainguinal peripheral artery disease: a meta-analysis of randomized controlled trials for the development of the Italian Guidelines for the treatment of diabetic foot syndrome.Alessia Scatena, Matteo Apicella, Michele Mantuano
|Sep 28, 2023
Limb Salvage and Survival in Chronic Limb-Threatening Ischemia: The Need for a Fast-Track Team-Based Approach.Giorgio Ventoruzzo, Giulia Mazzitelli, Umberto Ruzzi
|Jun 28, 2023
Finerenone: Questions and Answers-The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist.Luca Di Lullo, Carlo Lavalle, Alessia Scatena
|Jun 02, 2021
Autologous Peripheral Blood Mononuclear Cells for Limb Salvage in Diabetic Foot Patients with No-Option Critical Limb Ischemia.Alessia Scatena, Pasquale Petruzzi, Filippo Maioli
Pageof 2
